G

GKB Ophthalmics Ltd

GKBOPHTHALMICSLTD NSE

Key Fundamentals

MicrocapMedical EquipmentHealthcare
Market Cap
₹30.20 Cr
Volatility
Moderate
P/E Ratio
10
EBITDA
₹10.90 Cr
Return on Equity
5.52%
Debt to Equity
0.67
Book Value
₹104.82
EPS
₹0
52W High
₹91.7
52W Low
₹45.25

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view GKB Ophthalmics Ltd insights

42 extracted metrics + investor summaries across FY11–FY26.

Log in — free

Tapetide Score

Data-driven rating, 0–100. How it works →

Technical Indicators

Key Insights

Strengths

1
  • Company has reduced debt.

Weaknesses

6
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 3.74% over past five years.
  • Company has a low return on equity of -18.5% over last 3 years.
  • Earnings include an other income of Rs.4.18 Cr.
  • Company's cost of borrowing seems high
  • Promoter holding has decreased over last 3 years: -8.03%

Growth Rate

Revenue Growth
37.17% ↗
Net Income Growth
-142.25% ↘
Cash Flow Change
-11.08% ↘
ROE
-144.02% ↘
ROCE
-236.80% ↘
EBITDA Margin (Avg.)
-643.94% ↘

Quarterly Results

  Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales
6.47
9.71
7.27
6.84
7.36
8.62
8.26
7.45
8.43
8.77
6.11
4.36
6.4
Expenses
6.98
8.72
8.12
7.85
7.77
9.05
9.3
8.27
9.61
9.62
6.74
5.41
6.85
Operating Profit
-0.51
0.99
-0.85
-1.01
-0.41
-0.43
-1.04
-0.82
-1.18
-0.85
-0.63
-1.05
-0.45
OPM %
-7.88%
10.2%
-11.69%
-14.77%
-5.57%
-4.99%
-12.59%
-11.01%
-14%
-9.69%
-10.31%
-24.08%
-7.03%
Other Income
0.26
0.09
0.07
1.72
0.2
0.09
0.06
1.81
0.01
0.07
1.37
3.24
-0.5
Interest
0.4
0.37
0.38
0.36
0.48
0.41
0.4
0.48
0.6
0.68
0.57
0.6
0.32
Depreciation
1.55
0.64
0.65
0.66
0.64
0.65
0.66
0.67
0.66
0.67
0.68
0.68
0.66
PBT
-2.2
0.07
-1.81
-0.31
-1.33
-1.4
-2.04
-0.16
-2.43
-2.13
-0.51
0.91
-1.93
Tax %
-4.09%
0%
0%
0%
3.01%
0.71%
0.49%
6.25%
1.65%
0.94%
3.92%
-7.69%
-2.07%
Net Profit
-2.12
0.08
-1.81
-0.31
-1.37
-1.41
-2.05
-0.17
-2.48
-2.14
-0.52
0.98
-1.88
EPS in Rs
-4.21
0.16
-3.59
-0.62
-2.72
-2.8
-4.07
-0.34
-4.92
-4.25
-1.03
1.94
-3.73
Figures in ₹ Crores

Profit & Loss

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
29.85
31.17
40.65
37.43
30.47
25.56
21.34
27.05
27.73
31.18
32.75
25.64
Expenses
30.63
33.61
41.05
38.41
31.52
26.29
21.63
27.44
28.82
32.46
36.22
28.61
Operating Profit
-0.78
-2.44
-0.4
-0.98
-1.05
-0.73
-0.29
-0.39
-1.09
-1.28
-3.47
-2.97
OPM %
-2.61%
-7.83%
-0.98%
-2.62%
-3.45%
-2.86%
-1.36%
-1.44%
-3.93%
-4.11%
-10.6%
-11.58%
Other Income
1.72
23.08
4.11
1.05
2.62
1.38
2.33
1.91
2.09
2.08
1.97
4.18
Interest
2.49
1.61
1.26
1.23
1.39
1.35
1.34
1.34
1.5
1.59
1.89
2.17
Depreciation
1.48
1.42
1.34
1.58
3.43
3.47
2.99
2.49
2.54
2.59
2.64
2.69
PBT
-3.03
17.61
1.11
-2.74
-3.25
-4.17
-2.29
-2.31
-3.04
-3.38
-6.03
-3.65
Tax %
-25.41%
22.43%
31.53%
-6.2%
-14.77%
0%
-7.86%
0%
-5.26%
1.18%
1.16%
-2.19%
Net Profit
-2.26
13.66
0.76
-2.58
-2.78
-4.17
-2.11
-2.31
-2.88
-3.42
-6.11
-3.57
EPS in Rs
-5.44
32.89
1.83
-6.21
-5.99
-8.27
-4.19
-4.58
-5.71
-6.78
-12.12
-7.08
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
4.15
4.15
4.15
4.15
4.64
5.04
5.04
5.04
5.04
5.04
5.04
5.04
Reserves
11.14
24.8
25.44
22.78
30.03
30.21
27.73
25.36
22.48
18.95
12.63
9.28
Borrowings
8.62
7.22
7.19
9.93
10.05
10.04
11.97
11.75
11.22
11.08
18.09
9.54
Other Liabilities
24.79
11.36
10.22
8.57
10.45
11.4
12.13
11.74
10.41
13.32
13.72
12.75
Total Liabilities
48.7
47.53
47
45.43
55.17
56.69
56.87
53.89
49.15
48.39
49.48
36.61
Fixed Assets
11.72
12.49
16.43
16.98
24.29
24.83
22.28
21.27
17.28
15.89
14.44
12.49
CWIP
0.57
0.57
0.57
0.24
0
0
1.23
3.29
3.82
3.78
3.78
3.78
Investments
5.53
10.45
3.77
0.66
0.32
3.21
12.22
11.9
11.9
11.9
11.9
0.19
Other Assets
30.88
24.02
26.23
27.55
30.56
28.65
21.14
17.43
16.15
16.82
19.36
20.15
Total Assets
48.7
47.53
47
45.43
55.17
56.69
56.87
53.89
49.15
48.39
49.48
36.61
Figures in ₹ Crores

Cash Flow

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
5.87
-11.9
-4.2
-3.71
5.31
6.13
2.11
2.33
-1.14
1.36
-5.04
-1.48
Investing
0.13
14.74
5.5
2.28
-8.63
-5.68
-11.52
-0.83
2.4
0.37
-0.16
12.21
Financing
-6
-2.81
-1.29
1.41
9.21
3.31
0.61
-1.5
-2.03
-1.74
5.12
-10.72
Net Cash Flow
0
0.02
0
-0.02
5.88
3.76
-8.8
0
-0.78
0
-0.07
0
Free Cash Flow
5.24
-13.83
-9.08
-5.27
-4.35
2.44
-1.2
-1.34
0.25
0.16
-6.43
-2.06
CFO/OP
-1,028
202
725
366
-509
-841
-728
-600
101
-107
144
49
Figures in ₹ Crores

Ratios

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
177
92.63
66
102
129
148
127
80.96
64.23
80.3
83.48
73.74
Inventory Days
351
285
284
264
155
134
257
142
162
102
120
143
Days Payable
362
120
107
84.89
171
223
251
159
139
158
138
139
Cash Conversion Cycle
165
258
243
281
113
58.61
133
63.96
86.93
24.86
65.88
77.61
Working Capital Days
-21.15
69.79
80.72
94.59
-7.67
-56.12
-86.38
-85.68
-60.02
-85.22
-70.1
-34.17
ROCE %
-3.86%
-6.26%
-0.77%
-4.13%
-8.09%
-6.29%
0.13%
-2.14%
-3.96%
-4.96%
-11.8%
0.47%

Shareholding Pattern

As of Jun 2026
Promoters 51.15%
Public 38.97%
Others 8.09%
FIIs 1.79%
Total 100.00%
  Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters
59.44%
59.24%
59.58%
59.69%
59.72%
59.73%
59.16%
59.09%
59.09%
59.18%
50.86%
50.88%
50.93%
50.95%
50.95%
50.98%
50.99%
51.06%
51.06%
51.13%
51.13%
51.15%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
1.79%
1.79%
1.79%
1.79%
1.79%
1.79%
1.79%
1.79%
1.79%
1.79%
1.79%
1.79%
DIIs
0.39%
0.39%
0.00%
0.00%
0.00%
0.00%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Public
23.93%
24.44%
24.90%
24.48%
24.63%
24.79%
24.82%
24.79%
27.11%
27.40%
36.01%
36.04%
36.04%
36.64%
36.34%
36.96%
37.36%
37.22%
37.23%
38.55%
38.52%
38.97%
Others
16.24%
15.93%
15.52%
15.83%
15.65%
15.47%
16.01%
16.11%
13.79%
13.41%
11.34%
11.28%
11.23%
10.63%
10.93%
10.27%
9.87%
9.94%
9.93%
8.53%
8.57%
8.09%
No. of Shareholders
1,185
1,545
1,430
1,434
1,432
1,443
1,443
1,637
1,933
2,030
2,115
2,233
2,370
2,690
2,510
2,539
2,538
2,550
2,601
2,661
2,634
2,557

Documents

Frequently Asked Questions about GKB Ophthalmics Ltd

What does GKB Ophthalmics Ltd do?
Incorporated in 1981, GKB Ophthalmics Ltd is engaged in the manufacture and sale of ophthalmic lenses made up of Glass and Plastic.[1]
Where is GKB Ophthalmics Ltd (GKB) listed?
GKB Ophthalmics Ltd is listed on the Indian stock exchanges. It is listed on NSE: GKBOPHTHALMICSLTD and BSE: GKB. You can view its live share price, financials, and ratios on Tapetide.
Which sector does GKB Ophthalmics Ltd belong to?
GKB Ophthalmics Ltd operates in the Healthcare sector within the Medical Equipment industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of GKB Ophthalmics Ltd?
GKB Ophthalmics Ltd has a market capitalisation of approximately ₹30.20 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of GKB Ophthalmics Ltd?
The Price-to-Earnings (PE) ratio of GKB Ophthalmics Ltd is 10.00. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of GKB Ophthalmics Ltd?
Over the past 52 weeks, GKB Ophthalmics Ltd has traded between a low of ₹45.25 and a high of ₹91.7. This range helps investors understand the stock's price volatility and recent trading levels.
What is the Return on Equity (ROE) of GKB Ophthalmics Ltd?
GKB Ophthalmics Ltd has a Return on Equity (ROE) of 5.52%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research GKB Ophthalmics Ltd on Tapetide?
On Tapetide, you can view GKB Ophthalmics Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Incorporated in 1981, GKB Ophthalmics Ltd is engaged in the manufacture and sale of ophthalmic lenses made up of Glass and Plastic.[1]

Website gkb.net
CEO Mr. Krishna Gopal Gupta
Employees 170
Listed 2010-07-09
Face Value ₹ 10

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List